Member access

4-Traders Homepage  >  Shares  >  Tokyo  >  ONO PHARMACEUTICAL CO., LTD.    4528   JP3197600004

 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Company
Ono Pharmaceutical Co., Ltd. engages in the production, purchase, and sale of pharmaceutical and diagnostic reagents focusing on prescription pharmaceuticals.Its products include respiratory, digestive, urinary, chemotherapy, hormone, vitamins, and metabolic drugs.The company was founded by Ichibei... 
More about the company
Surperformance© ratings of ONO PHARMACEUTICAL CO., LT
Trading Rating : Investor Rating :
More Ratings
Chart ONO PHARMACEUTICAL CO., LT
Duration : Period :
ONO PHARMACEUTICAL CO., LT Technical Analysis Chart | 4528 | JP3197600004 | 4-Traders
Full-screen chart
Financials ( JPY)
Sales 2015 133 011 M
EBIT 2015 -
Net income 2015 12 634 M
Finance 2015 166 163 M
Yield 2015 1,54%
Sales 2016 143 893 M
EBIT 2016 -
Net income 2016 15 182 M
Finance 2016 157 346 M
Yield 2016 1,54%
PER 2015 103,34
PER 2016 79,21
EV / Sales 2015 9,13x
EV / Sales 2016 8,50x
Capitalization 1 379 994 M
More Financials
Latest news on ONO PHARMACEUTICAL CO., LT
01:08a ONO PHARMACEUTICAL : Amgen Announces Results from Phase 3 Clinical Study Compari..
02/17 AGILENT TECHNOLOGIES : Dako, an Agilent Technologies Company, and ONO PHARMACEUT..
02/16 ONO PHARMACEUTICAL : and Dako, an Agilent Technologies company announce collabor..
01/29 ONO PHARMACEUTICAL : Amgen submits applications in the us and europe for kyproli..
01/14 ONO PHARMACEUTICAL : CheckMate -017, A Phase 3 Study of Opdivo (Nivolumab) Compa..
01/14 ONO PHARMACEUTICAL : Outsourcing of Logistics Operation(38.9KB)
01/01 ONO PHARMACEUTICAL : and Gilead Announce Exclusive License Agreement to Develop ..
2014 GILEAD SCIENCES : ONO and Gilead Highlight Exclusive License Pact to Develop BTK..
More news
Sector news Generic Pharmaceuticals
06:31a ALEXION PHARMACEUTICALS : Joins Patient Organizations Worldwide in Support of In..
05:23a ASTRAZENECA : To Spin-out Early Stage Anti-Infectives R&D Company
03:21a AstraZeneca to carve out antibiotic R&D into separate firm
Plus d'actualités du secteur Generic Pharmaceuticals


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF